Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an In Situ Model of Oral Biofilm Growth: A Randomised Clinical Trial

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Cirurxía e Especialidades Médico-Cirúrxicasgl
dc.contributor.authorQuintas González, Víctor
dc.contributor.authorPrada López, Isabel
dc.contributor.authorDonos, Nikolaos
dc.contributor.authorSuárez Quintanilla, David
dc.contributor.authorTomás Carmona, Inmaculada
dc.date.accessioned2020-04-27T15:01:11Z
dc.date.available2020-04-27T15:01:11Z
dc.date.issued2015
dc.description.abstractObjective To evaluate the in situ antiplaque effect after 4 days of using of 2 commercial antimicrobial agents in short term on undisturbed plaque-like biofilm. Trial Design and Participants An observer-masked, crossover randomised clinical trial on 15 oral and systemically healthy volunteers between 20–30 years who were randomly and sequentially allocated in the same group which performed 3 interventions in different randomised sequences. Intervention The participants wore an appliance in 3 different rinsing periods doing mouthwashes twice a day (1/0/1) with essential oils, 0.2% chlorhexidine or sterile water (negative control). At the end of each 4-day mouthwash period, samples were removed from the appliance. Posteriorly, after bacterial vital staining, samples were analysed using a Confocal Laser Scanning Microscope. Main Outcome Measures Bacterial vitality, thickness and covering grade by the biofilm after 4 days of applying each of the mouthwashes. Results The essential oils and the 0.2% chlorhexidine were significantly more effective than the sterile water at reducing bacterial vitality, thickness and covering grade by the biofilm. No significant differences were found between the 0.2% chlorhexidine and the essential oils at reducing the bacterial vitality (13.2% vs. 14.7%). However, the 0.2% chlorhexidine showed more reduction than the essential oils in thickness (6.5 μm vs. 10.0 μm; p<0.05) and covering grade by the biofilm (20.0% vs. 54.3%; p<0.001). Conclusion The essential oils and 0.2% chlorhexidine showed a high antiplaque effect. Although the 0.2% chlorhexidine showed better results with regard to reducing the thickness and covering grade by the biofilm, both antiseptics showed a high and similar antibacterial activity. Clinical Relevance Daily essential oils or 0.2% chlorhexidine mouthwashes are effective when reducing dental plaque formation in the short term. Although 0.2% chlorhexidine continues to be the “gold standard” in terms of antiplaque effect, essential oils could be considered a reliable alternative. Trial Registration ClinicalTrials.gov NCT02124655gl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis work was supported by project PI11/01383 from Carlos III Institute of Health (General Division of Evaluation and Research Promotion, Madrid, Spain), which is integrated in National Plan of Research, Development and Innovation (PN I+D+I 2008-2011). This project was cofinanced by European Regional Development Fund (ERDF 2007-2013)gl
dc.identifier.citationQuintas V., Prada-López I., Donos N., Suárez-Quintanilla D., Tomás .I (2015). Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an In Situ Model of Oral Biofilm Growth: A Randomised Clinical Trial. PLoS ONE 10(2): e0117177gl
dc.identifier.doi10.1371/journal.pone.0117177
dc.identifier.essn1932-6203
dc.identifier.urihttp://hdl.handle.net/10347/21809
dc.language.isoenggl
dc.publisherPLOSgl
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0117177gl
dc.rightsCopyright: © 2015 Quintas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are creditedgl
dc.rights.accessRightsopen accessgl
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleAntiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an In Situ Model of Oral Biofilm Growth: A Randomised Clinical Trialgl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublication1c92ab4e-c290-4d02-88e4-35953d216344
relation.isAuthorOfPublicationf9cb8fca-ac19-4df5-819b-5a2dcf6ce966
relation.isAuthorOfPublication.latestForDiscovery1c92ab4e-c290-4d02-88e4-35953d216344

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2015_plos_quintas_antiplaque.PDF
Size:
761.25 KB
Format:
Adobe Portable Document Format
Description: